Landos Biopharma, Inc. (LABP) Financials
Stock symbol LABP is outdated, potentially delisted? Maybe it is available on other exchange?
LABP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Sept. 30, 2023 | 43.2 million | 5.6 million |
| June 30, 2023 | 46.3 million | 3.0 million |
| March 31, 2023 | 51.2 million | 4.2 million |
| Dec. 31, 2022 | 45.3 million | 6.1 million |
LABP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Sept. 30, 2023 | -2.2 million | 248000 |
| June 30, 2023 | -5.1 million | 254000 |
| March 31, 2023 | -8.2 million | 224000 |
| Dec. 31, 2022 | -3.7 million | 196000 |
LABP Net Income
No data available :(
LABP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Sept. 30, 2023 | 42.5 million | - | - |
| June 30, 2023 | 44.7 million | - | - |
| March 31, 2023 | 50.0 million | - | - |
| Dec. 31, 2022 | 44.4 million | - | - |
LABP Shares Outstanding
LABP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Sept. 30, 2023 | - | 3.1 million | 2.1 million | - |
| June 30, 2023 | - | 2.5 million | 2.0 million | - |
| March 31, 2023 | - | 3.3 million | 3.2 million | - |
| Dec. 31, 2022 | 7000 | 3.4 million | 3.1 million | - |
LABP Cost of Revenue
No data available :(
LABP
Price: $22.93
52 week price:
Earnings Per Share: -3.50 USD
P/E Ratio: -1.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 125700
Market Capitalization: 69.4 million